Cargando…
Human Norovirus: Experimental Models of Infection
Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410082/ https://www.ncbi.nlm.nih.gov/pubmed/30759780 http://dx.doi.org/10.3390/v11020151 |
_version_ | 1783402152597651456 |
---|---|
author | Todd, Kyle V. Tripp, Ralph A. |
author_facet | Todd, Kyle V. Tripp, Ralph A. |
author_sort | Todd, Kyle V. |
collection | PubMed |
description | Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo infection models has limited the development of HuNoV countermeasures. Experimental infection of human volunteers and the use of related viruses such as murine NoV have provided helpful insights into HuNoV biology and vaccine and therapeutic development. There remains a need for robust animal models and reverse genetic systems to further HuNoV research. This review summarizes available HuNoV animal models and reverse genetic systems, while providing insight into their usefulness for vaccine and therapeutic development. |
format | Online Article Text |
id | pubmed-6410082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64100822019-04-01 Human Norovirus: Experimental Models of Infection Todd, Kyle V. Tripp, Ralph A. Viruses Review Human noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo infection models has limited the development of HuNoV countermeasures. Experimental infection of human volunteers and the use of related viruses such as murine NoV have provided helpful insights into HuNoV biology and vaccine and therapeutic development. There remains a need for robust animal models and reverse genetic systems to further HuNoV research. This review summarizes available HuNoV animal models and reverse genetic systems, while providing insight into their usefulness for vaccine and therapeutic development. MDPI 2019-02-12 /pmc/articles/PMC6410082/ /pubmed/30759780 http://dx.doi.org/10.3390/v11020151 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Todd, Kyle V. Tripp, Ralph A. Human Norovirus: Experimental Models of Infection |
title | Human Norovirus: Experimental Models of Infection |
title_full | Human Norovirus: Experimental Models of Infection |
title_fullStr | Human Norovirus: Experimental Models of Infection |
title_full_unstemmed | Human Norovirus: Experimental Models of Infection |
title_short | Human Norovirus: Experimental Models of Infection |
title_sort | human norovirus: experimental models of infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410082/ https://www.ncbi.nlm.nih.gov/pubmed/30759780 http://dx.doi.org/10.3390/v11020151 |
work_keys_str_mv | AT toddkylev humannorovirusexperimentalmodelsofinfection AT trippralpha humannorovirusexperimentalmodelsofinfection |